T0	KEYPHRASE-NOTYPES 17 22	years
T1	KEYPHRASE-NOTYPES 37 59	Lyme disease incidence
T2	KEYPHRASE-NOTYPES 76 83	respect
T3	KEYPHRASE-NOTYPES 87 90	age
T4	KEYPHRASE-NOTYPES 105 110	rates
T5	KEYPHRASE-NOTYPES 117 125	children
T6	KEYPHRASE-NOTYPES 139 144	years
T7	KEYPHRASE-NOTYPES 149 155	adults
T8	KEYPHRASE-NOTYPES 170 175	years
T9	KEYPHRASE-NOTYPES 177 180	Fig
T10	KEYPHRASE-NOTYPES 193 206	United States
T11	KEYPHRASE-NOTYPES 212 221	incidence
T12	KEYPHRASE-NOTYPES 238 243	males
T13	KEYPHRASE-NOTYPES 251 261	age groups
T14	KEYPHRASE-NOTYPES 266 274	contrast
T15	KEYPHRASE-NOTYPES 276 283	females
T16	KEYPHRASE-NOTYPES 321 326	cases
T17	KEYPHRASE-NOTYPES 330 350	many European series
T18	KEYPHRASE-NOTYPES 364 373	incidence
T19	KEYPHRASE-NOTYPES 386 391	males
T20	KEYPHRASE-NOTYPES 409 415	series
T21	KEYPHRASE-NOTYPES 446 454	patterns
T22	KEYPHRASE-NOTYPES 470 498	behavior-related differences
T23	KEYPHRASE-NOTYPES 502 510	exposure
T24	KEYPHRASE-NOTYPES 518 529	populations
T25	KEYPHRASE-NOTYPES 531 534	age
T26	KEYPHRASE-NOTYPES 539 563	sex-specific differences
T27	KEYPHRASE-NOTYPES 567 581	susceptibility
T28	KEYPHRASE-NOTYPES 586 607	care-seeking behavior
T29	KEYPHRASE-NOTYPES 634 638	time
T30	KEYPHRASE-NOTYPES 644 656	US incidence
T31	KEYPHRASE-NOTYPES 696 701	males
T32	KEYPHRASE-NOTYPES 716 733	overall sex ratio
T33	KEYPHRASE-NOTYPES 743 747	male
T34	KEYPHRASE-NOTYPES 763 767	male
T35	KEYPHRASE-NOTYPES 787 808	sex-specific increase
T36	KEYPHRASE-NOTYPES 840 848	children
T37	KEYPHRASE-NOTYPES 855 872	separate analysis
T38	KEYPHRASE-NOTYPES 876 883	US data
T39	KEYPHRASE-NOTYPES 902 905	age
T40	KEYPHRASE-NOTYPES 910 926	sex distribution
T41	KEYPHRASE-NOTYPES 952 957	cases
T42	KEYPHRASE-NOTYPES 982 998	nonendemic areas
T43	KEYPHRASE-NOTYPES 1011 1032	high-incidence states
T44	KEYPHRASE-NOTYPES 1038 1047	modal age
T45	KEYPHRASE-NOTYPES 1052 1057	cases
T46	KEYPHRASE-NOTYPES 1064 1069	years
T47	KEYPHRASE-NOTYPES 1090 1095	males
T48	KEYPHRASE-NOTYPES 1100 1108	contrast
T49	KEYPHRASE-NOTYPES 1113 1130	nonendemic states
T50	KEYPHRASE-NOTYPES 1136 1145	modal age
T51	KEYPHRASE-NOTYPES 1153 1158	years
T52	KEYPHRASE-NOTYPES 1179 1184	males
T53	KEYPHRASE-NOTYPES 1194 1217	fundamental differences
T54	KEYPHRASE-NOTYPES 1221 1233	risk factors
T55	KEYPHRASE-NOTYPES 1238 1247	infection
T56	KEYPHRASE-NOTYPES 1254 1265	discrepancy
T57	KEYPHRASE-NOTYPES 1275 1292	misclassification
T58	KEYPHRASE-NOTYPES 1305 1327	substantial proportion
T59	KEYPHRASE-NOTYPES 1331 1340	illnesses
T60	KEYPHRASE-NOTYPES 1353 1369	nonendemic areas
T61	KEYPHRASE-NOTYPES 1393 1409	conditions
T62	KEYPHRASE-NOTYPES 1417 1424	finding
T63	KEYPHRASE-NOTYPES 1453 1457	risk
T64	KEYPHRASE-NOTYPES 1461 1473	misdiagnosis
T65	KEYPHRASE-NOTYPES 1477 1493	nonendemic areas
T66	KEYPHRASE-NOTYPES 1497 1508	consequence
T67	KEYPHRASE-NOTYPES 1516 1522	effect
T68	KEYPHRASE-NOTYPES 1526 1543	prior probability
T69	KEYPHRASE-NOTYPES 1551 1567	predictive value
T70	KEYPHRASE-NOTYPES 1584 1603	laboratory findings
